Definition, diagnosis and treatment of oligometastatic oesophagogastric cancer: A Delphi consensus study in Europe
Tiuri E. Kroese(University of Zurich), Jelle P. Ruurda(University Medical Center Utrecht), Maria Bencivenga(University of Verona), Theodore Liakakos(National and Kapodistrian University of Athens), Jolanda van Dieren(The Netherlands Cancer Institute), Maurice J.C. van der Sangen(Radboud University Nijmegen), Mark I. van Berge Henegouwen(University of Namur), Guillaume Piessen(Centre Hospitalier Universitaire de Lille), Geert-Jan Creemers, Pieter Deseyne(Ghent University Hospital), Johanna W. van Sandick(Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital), Radka Obermannová(Masaryk University), Antoine Adenis(Inserm), Bas P. L. Wijnhoven(Erasmus MC Cancer Institute), Sebastian F. Schoppman(Medical University of Vienna), Hanneke W.M. van Laarhoven(Dutch Cancer Society), Paul M. Jeene(Radiotherapiegroep), John V. Reynolds(Trinity College), Grard A. P. Nieuwenhuijzen(Radboud University Nijmegen), Markus Moehler(Johannes Gutenberg University Mainz), A.G. Morganti(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Cihan Gani(German Cancer Research Center), Laurens V. Beerepoot(Elisabeth-TweeSteden Ziekenhuis), Marcel Verheij(Radboud University Nijmegen), Christiane J. Bruns, Florian Lordick(Leipzig University), Marieke A. Vollebergh(Molecular Oncology (United States)), Franco Roviello(University of Siena), Karin Haustermans(Radboud University Nijmegen), Philippe Nafteux(KU Leuven), Marije Slingerland(Leiden University Medical Center), Riccardo Rosati(Universität Hamburg), Francine E.M. Voncken(The Netherlands Cancer Institute), Stella Mook(Utrecht University), Giovanni De Manzoni(University of Verona), Ines Gockel(University Hospital of Basel), Per Pfeiffer(University of Southern Denmark), Francesco Cellini(Università Cattolica del Sacro Cuore), Carlo Castoro(Humanitas University), Marianne Nordsmark(Aarhus University Hospital), Maarten C.C.M. Hulshof(Academic Medical Center), C.T. Muijs(University Medical Center Groningen), Nadia Haj Mohammad(Utrecht University), Maaike Berbée(Maastro Clinic), Eric Van Cutsem(Universitair Ziekenhuis Leuven), Hanna Rahbek Mortensen(Aarhus University), Mélissa Thomas(AZ Sint-Lucas), Anneli Elme(North Estonia Medical Centre), Henk H. Hartgrink(Leiden University Medical Center), Domenico D’Ugo(Agostino Gemelli University Polyclinic)
Cited by 58
Related Papers
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
|New England Journal of Medicine|2013|6.6k
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
|New England Journal of Medicine|2012|5.5k
Gastric cancer
|The Lancet|2020|4.8k
Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors
|New England Journal of Medicine|2017|3.2k